Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.

Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

Hypertension. 2005 Dec;46(6):1309-15. Epub 2005 Nov 14.

2.

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr, Oakes R, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

JAMA. 2004 Nov 10;292(18):2227-36.

PMID:
15536109
3.

Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.

Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V.

J Diabetes Complications. 2008 Sep-Oct;22(5):303-8. doi: 10.1016/j.jdiacomp.2007.05.003. Epub 2008 Apr 16.

4.

Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.

Wright JT Jr, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M.

J Clin Hypertens (Greenwich). 2007 Nov;9(11):842-9.

5.

Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Bakris GL; GEMINI Investigators.

J Cardiometab Syndr. 2008 Fall;3(4):211-7. doi: 10.1111/j.1559-4572.2008.00017.x.

6.

Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.

Bell DS, Bakris GL, McGill JB.

Diabetes Obes Metab. 2009 Mar;11(3):234-8. doi: 10.1111/j.1463-1326.2008.00927.x. Epub 2008 Jun 17.

PMID:
18564334
7.

beta-blocker use and diabetes symptom score: results from the GEMINI study.

McGill JB, Bakris GL, Fonseca V, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Dalal MR, Bell DS.

Diabetes Obes Metab. 2007 May;9(3):408-17.

PMID:
17391169
8.

Body weight changes with beta-blocker use: results from GEMINI.

Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT Jr, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL; GEMINI Investigators.

Am J Med. 2007 Jul;120(7):610-5.

PMID:
17602935
9.

The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.

Bakris GL, Bell DS, Fonseca V, Katholi R, McGill J, Phillips R, Raskin P, Wright JT Jr, Iyengar M, Holeslaw T, Anderson KM; GEMINI Investigators.

J Diabetes Complications. 2005 Mar-Apr;19(2):74-9.

PMID:
15745836
10.
11.

Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).

Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA; COMET investors.

Eur J Heart Fail. 2005 Jun;7(4):640-9.

12.

Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM.

Am J Hypertens. 2007 Jul;20(7):777-83.

PMID:
17586413
13.

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.

Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.

J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.

14.

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.

Sanderson JE, Chan SK, Yip G, Yeung LY, Chan KW, Raymond K, Woo KS.

J Am Coll Cardiol. 1999 Nov 1;34(5):1522-8.

15.

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.

Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A; COMET Investigators.

Am Heart J. 2005 Feb;149(2):370-6.

PMID:
15846279
16.

Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.

Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C.

Vasc Health Risk Manag. 2007;3(1):31-7. Review.

17.

Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.

Weber K, Bohmeke T, van der Does R, Taylor SH.

Cardiovasc Drugs Ther. 1996 May;10(2):113-7.

PMID:
8842502
18.

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.

Wong GW, Laugerotte A, Wright JM.

Cochrane Database Syst Rev. 2015 Aug 26;(8):CD007449. doi: 10.1002/14651858.CD007449.pub2. Review.

PMID:
26306578
19.
20.

Supplemental Content

Support Center